相关实验视频
Updated: Jun 4, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
陈列药和非酒精性脂肪性肝病:简要的综述
Evelyn Nunes Goulart da Silva Pereira1, Rafaela Luiza Costa Franco1, Rafaele Dantas Cruz Dos Santos1
1Laboratory of Clinical and Experimental Physiopathology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.
在非酒精性脂肪性肝病 (NAFLD) 中,除了降低胆固醇,他类药物可能还能提供治疗效益. 需要进一步的研究来确认它们在治疗像NAFLD这样的肝脏疾病中的有效性.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
- 代谢综合征是代谢综合征的一种.
背景情况:
- 非酒精性脂肪肝 (NAFLD) 影响全球20-30%的成年人,与代谢综合征和心血管风险增加有关.
- NAFLD包括简单的肥胖症和非酒精性肥胖肝炎,挑战患者对生活方式修改的坚持.
- 目前的NAFLD治疗缺乏特异性,促使研究药物重新定位策略.
研究的目的:
- 审查目前对他类药物对NAFLD肝脏生理学影响的理解.
- 探索他类药物作为NAFLD的替代治疗策略的潜力.
- 为未来关于在NAFLD治疗中使用他类药物的研究提供基础.
主要方法:
- 文献综述侧重于他类药物和NAFLD.
- 分析除了降低胆固醇之外的他类药物的机制.
- 检查他类药物对NAFLD病理生理学的影响 (肥胖症,炎症,纤维化).
主要成果:
- 类他类药物抑制3 - 基-3 - 甲基氨酸-CoA减少酶,影响除了降脂之外的途径.
- 类他类药物的性作用包括对炎症的调节,纤维生成,氧化应激和微循环.
- 临床指导方针建议在NAFLD患者中使用他类药物治疗脱脂症,但直接肝脏疗效需要更多的研究.
结论:
- 类药物具有与NAFLD病理生理学相关的多方面的作用.
- 虽然在NAFLD中对失脂症有益,但直接肝脏治疗的确证据尚未得到证实.
- 对他类药物对NAFLD的治疗潜力进行进一步的研究是有必要的.
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...